Krol WL - Search Results

1

Differential UGT1A1 induction by chrysin in primary human hepatocytes and HepG2 Cells.

Smith CM, Graham RA, Krol WL, Silver IS, Negishi M, Wang H, Lecluyse EL. Smith CM, et al. Among authors: krol wl. J Pharmacol Exp Ther. 2005 Dec;315(3):1256-64. doi: 10.1124/jpet.105.090795. Epub 2005 Aug 31. J Pharmacol Exp Ther. 2005. PMID: 16135700

2

Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes.

Graham RA, Tyler LO, Krol WL, Silver IS, Webster LO, Clark P, Chen L, Banks T, LeCluyse EL. Graham RA, et al. Among authors: krol wl. J Biochem Mol Toxicol. 2006;20(2):69-78. doi: 10.1002/jbt.20118. J Biochem Mol Toxicol. 2006. PMID: 16615094

3

Cloning, tissue expression, and regulation of beagle dog CYP4A genes.

Graham RA, Goodwin B, Merrihew RV, Krol WL, Lecluyse EL. Graham RA, et al. Among authors: krol wl. Toxicol Sci. 2006 Aug;92(2):356-67. doi: 10.1093/toxsci/kfl009. Epub 2006 May 4. Toxicol Sci. 2006. PMID: 16675513

4

Comparison of the hemoglobin adducts formed by administration of N-methylolacrylamide and acrylamide to rats.

Fennell TR, Snyder RW, Krol WL, Sumner SC. Fennell TR, et al. Among authors: krol wl. Toxicol Sci. 2003 Feb;71(2):164-75. doi: 10.1093/toxsci/71.2.164. Toxicol Sci. 2003. PMID: 12563102

5

Acrylamide: a comparison of metabolism and hemoglobin adducts in rodents following dermal, intraperitoneal, oral, or inhalation exposure.

Sumner SC, Williams CC, Snyder RW, Krol WL, Asgharian B, Fennell TR. Sumner SC, et al. Among authors: krol wl. Toxicol Sci. 2003 Oct;75(2):260-70. doi: 10.1093/toxsci/kfg191. Epub 2003 Jul 25. Toxicol Sci. 2003. PMID: 12883088

6

Pharmacokinetics of dibutylphthalate in pregnant rats.

Fennell TR, Krol WL, Sumner SC, Snyder RW. Fennell TR, et al. Among authors: krol wl. Toxicol Sci. 2004 Dec;82(2):407-18. doi: 10.1093/toxsci/kfh294. Epub 2004 Sep 29. Toxicol Sci. 2004. PMID: 15456918

7

Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs.

Grabenauer M, Krol WL, Wiley JL, Thomas BF. Grabenauer M, et al. Among authors: krol wl. Anal Chem. 2012 Jul 3;84(13):5574-81. doi: 10.1021/ac300509h. Epub 2012 Jun 20. Anal Chem. 2012. PMID: 22724537 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters